RJA
EIGR

Raymond James & Associates’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Raymond James & Associates’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-77
Closed -$657K – 2447
2015
Q1 		$657K Buy
77
+37
+93% +$316K ﹤0.01% 1897
2014
Q4 		$355K Buy
+40
New +$355K ﹤0.01% 2060